AbbVie is a global biopharmaceutical company focused on developing advanced therapies that address some of the world’s most complex and serious diseases. AbbVie is a leader in addressing these challenges, with an expanded focus on biologics and “targeted medicine.” We use our knowledge and expertise to develop therapies that address difficult conditions that affect significant patient populations. Our priority is our patients and helping them lead healthier lives.
AbbVie has a solid financial foundation, strong product portfolio and compelling new product pipeline that provides us with the resources we need today and for the long-term. We have delivered industry-leading pharmaceutical performance over the last decade. Our senior leadership understands how to manage our company and its 30,000 employees for success and long-term, profitable growth. Upon merging with Shire in 2014 our global footprint serves patients in 170 countries. We have 9 global R&D, 14 manufacturing sites and 9 leading products in the market.